Fasinex 5% w/v Oral Suspension
Fasinex 5% w/v Oral Suspension
Authorised
- Triclabendazole
Product identification
Medicine name:
Fasinex 5% w/v Oral Suspension
Active substance:
- Triclabendazole
Target species:
-
Sheep
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Triclabendazole50.00milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Oral suspension
Withdrawal period by route of administration:
-
Oral use
- Sheep
-
Meat and offal55day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AC
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Ireland
Package description:
- 12 litre HDPE containers
- 2.2 litre HDPE containers
- 0.8 litre HDPE containers
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Elanco France S.A.S
Responsible authority:
- Health Products Regulatory Authority
Authorisation number:
- VPA22020/004/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 8/04/2022
How useful was this page?: